These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25042364)

  • 21. Development and Validation of the Pediatric Charcot-Marie-Tooth Disease Quality of Life Outcome Measure.
    Ramchandren S; Wu TT; Finkel RS; Siskind CE; Feely SME; Burns J; Reilly MM; Estilow T; Shy ME;
    Ann Neurol; 2021 Feb; 89(2):369-379. PubMed ID: 33222249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles.
    Gallardo E; García A; Combarros O; Berciano J
    Brain; 2006 Feb; 129(Pt 2):426-37. PubMed ID: 16317020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel outcome measures for Charcot-Marie-Tooth disease: validation and reliability of the 6-min walk test and StepWatch(™) Activity Monitor and identification of the walking features related to higher quality of life.
    Padua L; Pazzaglia C; Pareyson D; Schenone A; Aiello A; Fabrizi GM; Cavallaro T; Santoro L; Manganelli F; Gemignani F; Vitetta F; Quattrone A; Mazzeo A; Russo M; Vita G;
    Eur J Neurol; 2016 Aug; 23(8):1343-50. PubMed ID: 27160471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Balance impairment in pediatric charcot-marie-tooth disease.
    Estilow T; Glanzman AM; Burns J; Harrington A; Cornett K; Menezes MP; Shy R; Moroni I; Pagliano E; Pareyson D; Bhandari T; Muntoni F; Laurá M; Reilly MM; Finkel RS; Eichinger KJ; Herrmann DN; Troutman G; Bray P; Halaki M; Shy ME; Yum SW;
    Muscle Nerve; 2019 Sep; 60(3):242-249. PubMed ID: 31026080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pain assessment in Charcot-Marie-Tooth (CMT) disease.
    Ribiere C; Bernardin M; Sacconi S; Delmont E; Fournier-Mehouas M; Rauscent H; Benchortane M; Staccini P; Lantéri-Minet M; Desnuelle C
    Ann Phys Rehabil Med; 2012 Apr; 55(3):160-73. PubMed ID: 22475878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ascorbic acid for the treatment of Charcot-Marie-Tooth disease.
    Gess B; Baets J; De Jonghe P; Reilly MM; Pareyson D; Young P
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD011952. PubMed ID: 26662471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry.
    Bellofatto M; Bertini A; Tramacere I; Manganelli F; Fabrizi GM; Schenone A; Santoro L; Cavallaro T; Grandis M; Previtali SC; Allegri I; Padua L; Pazzaglia C; Calabrese D; Saveri P; Quattrone A; Valentino P; Tozza S; Gentile L; Russo M; Mazzeo A; Vita G; Piacentini S; Pisciotta C; Pareyson D;
    J Neurol; 2023 Jan; 270(1):394-401. PubMed ID: 36114297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The audiologic profile of patients with Charcot-Marie Tooth neuropathy can be characterised by both cochlear and neural deficits.
    Giuliani N; Holte L; Shy M; Grider T
    Int J Audiol; 2019 Dec; 58(12):902-912. PubMed ID: 31318300
    [No Abstract]   [Full Text] [Related]  

  • 29. Quantitative muscle ultrasound as a biomarker in Charcot-Marie-Tooth neuropathy.
    Shahrizaila N; Noto Y; Simon NG; Huynh W; Shibuya K; Matamala JM; Dharmadasa T; Devenney E; Kennerson ML; Nicholson GA; Kiernan MC
    Clin Neurophysiol; 2017 Jan; 128(1):227-232. PubMed ID: 27940147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body composition and its association with physical performance, quality of life, and clinical indictors in Charcot-Marie-Tooth disease: a pilot study.
    Hackett D; Roberts-Clarke D; Jain N; Mavros Y; Wilson GC; Halaki M; Burns J; Nicholson G; Fiatarone Singh M; Fornusek C
    Disabil Rehabil; 2019 Feb; 41(4):405-412. PubMed ID: 29096547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining disability: development and validation of a mobility-Disability Severity Index (mDSI) in Charcot-Marie-tooth disease.
    Ramchandren S; Shy M; Feldman E; Carlos R; Siskind C
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):635-9. PubMed ID: 25157034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease.
    Sevilla T; Lupo V; Martínez-Rubio D; Sancho P; Sivera R; Chumillas MJ; García-Romero M; Pascual-Pascual SI; Muelas N; Dopazo J; Vílchez JJ; Palau F; Espinós C
    Brain; 2016 Jan; 139(Pt 1):62-72. PubMed ID: 26497905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of functional surgery associated with early intensive rehabilitation therapy in Charcot-Marie-Tooth Type 1A disease.
    Ferraro F; Dusina B; Carantini I; Strambi R; Galante E; Gaiani L
    Eur J Phys Rehabil Med; 2017 Oct; 53(5):788-793. PubMed ID: 28264542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of focal mechanic vibration treatment on balance in Charcot-Marie-Tooth 1A disease: a pilot study.
    Pazzaglia C; Camerota F; Germanotta M; Di Sipio E; Celletti C; Padua L
    J Neurol; 2016 Jul; 263(7):1434-41. PubMed ID: 27177999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective observational study of the main features of nocturnal leg cramps in primary care.
    Sebo P; Haller D; Cerutti B; Maisonneuve H
    Swiss Med Wkly; 2019 Mar; 149():w20048. PubMed ID: 30905059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in walking velocity and stride parameters with age in children with Charcot-Marie-Tooth disease.
    Õunpuu S; Pierz KA; Acsadi G; Wren TAL
    Neuromuscul Disord; 2020 Oct; 30(10):825-832. PubMed ID: 32928646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The EGR2 gene is involved in axonal Charcot-Marie-Tooth disease.
    Sevilla T; Sivera R; Martínez-Rubio D; Lupo V; Chumillas MJ; Calpena E; Dopazo J; Vílchez JJ; Palau F; Espinós C
    Eur J Neurol; 2015 Dec; 22(12):1548-55. PubMed ID: 26204789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.
    Verhamme C; van Schaik IN; Koelman JH; de Haan RJ; de Visser M
    Brain; 2009 Dec; 132(Pt 12):3252-62. PubMed ID: 19843647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deterioration in gait and functional ambulation in children and adolescents with Charcot-Marie-Tooth disease over 12 months.
    Kennedy R; Carroll K; Paterson KL; Ryan MM; McGinley JL
    Neuromuscul Disord; 2017 Jul; 27(7):658-666. PubMed ID: 28495045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term walking ability and patient satisfaction after lower limb functional surgery in patients affected by Charcot-Marie-Tooth disease: A retrospective study.
    Carantini I; Merlo A; Esposito D; Zerbinati P; Gaiani L; Ferraro F
    J Peripher Nerv Syst; 2020 Sep; 25(3):297-302. PubMed ID: 32662923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.